Colitis Home > Cimzia and Breastfeeding
Before using Cimzia (certolizumab pegol), breastfeeding women should consult their healthcare providers about any potential risks. Since no clinical studies have been conducted on breastfeeding and Cimzia, it is not known whether this medication passes through breast milk. It is also not known if Cimzia would cause any problems in a nursing infant, as the drug has not been studied in children.
It is not known if Cimzia® (certolizumab pegol) passes through breast milk in humans. The manufacturer of Cimzia recommends avoiding Cimzia while breastfeeding. Therefore if you are breastfeeding, you should talk with your healthcare provider before taking Cimzia.
No research has been done to see if Cimzia passes through breast milk in humans. Similarly, it is not known if it would cause any problems in a breastfed infant, since the medication has not been studied in children.
In general, very little is known about most drugs and breastfeeding, since it is usually considered to be unethical to study medications in breastfeeding women. Although this lack of information can be frustrating, it is important to understand that this is done to protect babies who cannot protect themselves.
You should talk with your healthcare provider about Cimzia and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision that is right for you.